Search

Search results

1. Canadian patients suffer lack of access to cancer drugs

   New research by scholars at the University of Pittsburgh shows how bad access to new cancer medicines is in Canada, especially compared to the United States: Of 45 anticancer drug indications approved in the United States between January ...

2. U.S. should follow Canada’s lead on EpiPens

   If you follow the health reform debate in the United States, you know that every once in a while a pharmaceutical executive decides to poke the political dragon by jacking up the price of a prescription drug. This time around, it is ...